Similar articles

• Soframycin: its penetration into the eye and its effect upon experimentally produced Staph. aureus and Ps. pyocyanea corneal infections.

  AINSLIE D, HENDERSON WG. AINSLIE D, et al. Br J Ophthalmol. 1958 Sep;42(9):513-7. doi: 10.1136/bjo.42.9.513. Br J Ophthalmol. 1958. PMID: 13572765 Free PMC article. No abstract available.
• Framycetin sulphate (Soframycin) as a pre-operative bowel-sterilizing agent.

  HORSBURGH AG. HORSBURGH AG. Gut. 1961 Mar;2(1):51-2. doi: 10.1136/gut.2.1.51. Gut. 1961. PMID: 13715949 Free PMC article.
• Recurrence of staphylococci of same phage-type following control of nasal carriers with neobacrin and soframycin.

  JARVIS AW, WIGLEY CF. JARVIS AW, et al. Lancet. 1961 Nov 25;2(7213):1168-70. doi: 10.1016/s0140-6736(61)90844-3. Lancet. 1961. PMID: 14451371 No abstract available.
• Pharmacokinetic considerations in the treatment of bacterial keratitis.

  Callegan MC, O'Callaghan RJ, Hill JM. Callegan MC, et al. Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005. Clin Pharmacokinet. 1994. PMID: 7955776 Review.
• Antibiotic therapy for ocular infection.

  Snyder RW, Glasser DB. Snyder RW, et al. West J Med. 1994 Dec;161(6):579-84. West J Med. 1994. PMID: 7856158 Free PMC article. Review.